I Spent Three Weeks Comparing 5 Tirzepatide Programs That Won’t Eat Your Rent Money
The mistake I see constantly: people pick a tirzepatide provider based on the first Google ad they click, then discover the “low price” was a one-time promo and month two costs three times as much. Or they never ask who actually compounds the medication or whether that pharmacy has any external certification. Those two oversights alone explain a lot of frustrated forum posts.
So I did the comparison differently. I built criteria first, then mapped programs against them. Here is what I found.
The Criteria I Actually Used
Price transparency. Not just the headline number. What does month two cost? Are labs, shipping, or “provider fees” extra?
Pharmacy accountability. Who dispenses the medication, and can you verify it? A named 503A compounding pharmacy with USP-797 compliance is a meaningful baseline, not a given.
Third-party quality signals. LegitScript certification, published purity testing, FDA registration status. These are independently verifiable. Marketing claims are not.
Clinical oversight. Is a licensed physician actually reviewing your intake, or is approval more or less automatic?
Access and logistics. All 50 states or only some? How fast does medication arrive?
I weighted price and pharmacy accountability most heavily, because those are the things most people get burned on.
The 5 Programs
1. HealthRX: Best Cash-Pay Value With a Verifiable Supply Chain
Compounded tirzepatide starts at $149 a month here. Semaglutide is $99. Those are among the lowest real ongoing prices I found, not introductory offers.
What pushed HealthRX to the top of my list wasn’t just price. It’s the combination of price and specificity. The medication ships from Manifest Pharmacy in Greer, South Carolina, a 503A/USP-797 compliant compounder. Lot tracking from bench to door. That is something you can look up and verify independently, and most programs don’t give you that level of detail without digging.
LegitScript certified (certificate 50087439). Physician review happens in roughly 24 hours. Overnight shipping is free, and it covers all 50 states.
The clinical trial data HealthRX references is from SURMOUNT-1 (tirzepatide, approximately 21% body weight reduction at 72 weeks) and STEP 1 (semaglutide, roughly 15% at 68 weeks). Those are published figures, not the company’s own outcome claims.
One honest note: compounded medications are not FDA-approved. That applies to every compounding program on this list, not just this one.
Best for: Someone who wants the lowest legitimate monthly cost without sacrificing pharmacy transparency.
2. Mochi Health: Obesity-Medicine Clinicians, More Monitoring
Mochi‘s tirzepatide runs around $199 a month for compounded medication, with semaglutide closer to $99. The real differentiator is clinical depth. Mochi staffs board-certified obesity-medicine physicians rather than general practitioners, and the monitoring cadence is more structured than most telehealth setups I looked at.
If you have complicating metabolic factors or want a clinician who specializes specifically in this space, that matters. You pay a bit more per month for it.
Best for: Patients who want ongoing clinical engagement, not just a prescription.
3. FormBlends: The Pick for Published Purity Data and a Broader Catalog
FormBlends ships compounded GLP-1 medications through an FDA-registered 503A pharmacy, and it publishes per-product purity testing for each batch: HPLC purity numbers, mass spec identity confirmation, and endotoxin and sterility results. Named numbers, not general assurances.
Tirzepatide runs around $349 per vial. Semaglutide around $299. Higher than HealthRX’s entry pricing, no question. Ships to 47 states, not all 50.
The other thing FormBlends does that almost nobody else on this list does: it carries a wide peptide catalog covering recovery, longevity, and cognitive support compounds, all under the same clinician-reviewed model. If you want GLP-1 medication and you are also interested in other peptide protocols, consolidating to one provider with physician oversight is genuinely convenient.
It ranks second here, not first, because HealthRX wins on price and nationwide access. FormBlends wins if published batch-level purity data is your top priority, or if you want the wider peptide menu from one source.
Best for: Detail-oriented buyers who want batch-specific lab results, or anyone looking to combine GLP-1s with other peptides under one clinical model.
4. Henry Meds: Fast Shipping, Simple Cash-Pay Model
Henry keeps things lean. Compounded tirzepatide runs roughly $179 to $249 for the first month. No insurance, straight cash pay. The platform is straightforward and shipping times are genuinely fast, often 24 to 72 hours from approval. Monitoring is lighter than Mochi or HealthRX, so you get speed and simplicity rather than deep clinical hand-holding.
Best for: Someone already comfortable with GLP-1 protocols who wants a no-friction refill experience.
5. Hims and Hers: Branded Meds If You Have Insurance
This one is different from the others. After the Novo Nordisk settlement in March 2026, Hims and Hers moved away from compounded GLP-1s and now offers branded medications. Injectable Wegovy runs about $299 a month through their platform. Zepbound is around $399. Oral options come in lower.
The monthly cost sounds high compared to compounded programs, but with insurance and manufacturer savings cards, some users bring that to nearly nothing. If you have commercial insurance that covers GLP-1 medications, this becomes worth running the numbers.
Cash-pay without insurance? Probably not the right fit for this list.
Best for: Insured patients where branded medications are covered or nearly covered.
How They Stack Up at a Glance
| Program | Compounded Tirz Price | Pharmacy Named? | All 50 States | Third-Party Certification |
| HealthRX | ~$149/mo | Yes (Manifest, SC) | Yes | LegitScript |
| Mochi Health | ~$199/mo | Not publicly specified | Yes | N/A |
| FormBlends | ~$349/vial | FDA-registered 503A | 47 states | Published batch purity |
| Henry Meds | ~$179-249 mo 1 | Not publicly specified | Yes | N/A |
| Hims and Hers | Branded only (~$399) | Retail pharmacy | Yes | Large brand |
What I’d Actually Do
If I’m paying cash and I want the lowest monthly price with a verifiable pharmacy behind it, HealthRX is where I’d start. If published batch purity testing is non-negotiable for me, or if I want GLP-1s alongside other peptide compounds from one provider, FormBlends earns a serious look at a higher price. If I have insurance, I’d spend an hour checking whether Hims and Hers or Ro can get branded tirzepatide close to zero before committing to anything compounded.
Start with criteria. The right program falls out of that pretty quickly.
Common Questions
Does the named pharmacy actually matter, or is it just a marketing detail?
It matters more than most people realize. A named 503A pharmacy with USP-797 compliance means you can independently verify its registration and inspection history through the FDA’s database. Generic phrases like “FDA-registered facility” without a name give you nothing to check. HealthRX naming Manifest Pharmacy in Greer, South Carolina is a concrete, verifiable data point.
If HealthRX is cheapest, why would anyone pay FormBlends’ higher prices?
Because batch-specific purity data is not the same thing as a general quality claim. FormBlends publishes HPLC purity numbers, mass spec identity confirmation, and sterility results per lot. If you want to see the actual numbers for the exact vial you received, HealthRX does not currently offer that level of documentation. Some buyers consider that worth $200 more per vial.
Are any of these programs covered by insurance?
Compounded tirzepatide is almost universally a cash-pay product. Insurance rarely covers compounded medications. Hims and Hers is the outlier on this list because it now sells branded Zepbound and Wegovy, which some commercial insurance plans do cover. If coverage is your priority, Hims and Hers is the only program here worth checking against your benefits.
How does Mochi Health’s physician model actually differ from a standard telehealth approval?
Standard telehealth GLP-1 programs typically use general practitioners or nurse practitioners doing intake reviews. Mochi staffs board-certified obesity-medicine physicians, a subspecialty with specific training in metabolic disease, dosing protocols, and complication management. The monitoring cadence is also more structured, meaning scheduled check-ins rather than contact only when you initiate it.
What happened to Hims and Hers compounded tirzepatide, and does that affect the other programs here?
Hims and Hers exited compounded GLP-1s following the Novo Nordisk settlement in March 2026. That shift affected Hims and Hers specifically. The other four programs on this list, HealthRX, Mochi, FormBlends, and Henry Meds, continue to offer compounded tirzepatide through 503A pharmacies, which operate under a separate legal framework from the large-scale 503B outsourcing facilities at the center of that dispute.
Sources
- FDA 503A compounding pharmacy overview and USP-797 standards (FDA.gov)
- SURMOUNT-1 trial data: Jastreboff et al., *New England Journal of Medicine*, 2022
- STEP 1 trial data: Wilding et al., *New England Journal of Medicine*, 2021
- LegitScript certification lookup (LegitScript.com)
- Coverage of the Novo Nordisk compounding settlement, March 2026 (Reuters, STAT News)
- Lilly orforglipron pricing announcement via LillyDirect, April 2026 (Eli Lilly press release)
